Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost Monotherapy vs. Travoprost/Timolol Dual Therapy in Glaucoma and Ocular Hypertension
NCT00348023Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bimatoprost in Glaucoma, ocular hypertension, sponsored by Janssen Pharmaceutical. Status: completed.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00348023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348023.